Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gallbladder Neoplasms × Electroporation × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18 Carcinoma, Hepatocellular 7 Liver Neoplasms 6 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Neoplasm Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Liver Metastasis Colon Cancer 1 Liver Diseases 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Bile Duct Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Gemcitabine 54 Cisplatin 36 Capecitabine 28 Oxaliplatin 27 Fluorouracil 21 Leucovorin 19 Irinotecan 12 pembrolizumab 11 durvalumab 9 130-nm albumin-bound paclitaxel 9 Erlotinib Hydrochloride 8 Trastuzumab 7 Bevacizumab 7 Taxes 5 Radiotherapy 5 Docetaxel 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Platinum 4 Immunohistochemistry 4 1,2-diaminocyclohexaneplatinum II citrate 4 trifluridine tipiracil drug combination 3 Watchful Waiting 3 S 1 (combination) 3 Paclitaxel 3 Observation 3 Magnetic Resonance Spectroscopy 3 Epirubicin 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430662 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡